Selective changes in nicotinic acetylcholine receptor subtypes related to tobacco smoking: An immunohistochemical study

Neuropathology and Applied Neurobiology

Volumn 30, Issue 3, 2004, Pages 243-254

  Teaktong, T ^a   Graham, A J ^a   Johnson, M ^a   Court, J A ^a   Perry, E K ^a  

^a NEWCASTLE GENERAL HOSPITAL   (United Kingdom)

Author keywords

4 subunit; 7 subunit; Astrocytes; Cigarette smoking; Entorhinal cortex; Hippocampus; Nicotinic receptors

Indexed keywords

NICOTINE; NICOTINIC AGENT; NICOTINIC RECEPTOR; RECEPTOR SUBTYPE;

ADULT; AGED; ALZHEIMER DISEASE; ANAMNESIS; ARTICLE; ASTROCYTE; CLINICAL ARTICLE; COMPARATIVE STUDY; DENTATE GYRUS; DOWN REGULATION; ENTORHINAL CORTEX; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; NEUROPIL; PERIKARYON; PRIORITY JOURNAL; SMOKING; STATISTICAL SIGNIFICANCE; UPREGULATION;

AGED; ASTROCYTES; DENDRITES; DENTATE GYRUS; ENTORHINAL CORTEX; GLIAL FIBRILLARY ACIDIC PROTEIN; HIPPOCAMPUS; HUMANS; IMMUNOHISTOCHEMISTRY; PRESYNAPTIC TERMINALS; RECEPTORS, NICOTINIC; SMOKING; SMOKING CESSATION; UP-REGULATION;

EID: 2942703954     PISSN: 03051846     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.0305-1846.2003.00528.x     Document Type: Article

References (69)

1. Gotti C, Fornasari D, Clementi F. Human neuronal nicotinic receptors. Prog Neurobiol 1997; 53: 199-237
2. Wonnacott S. Presynaptic nicotinic ACh receptors. Trends Neurosci 1997; 20: 92-8
3. Zoli M, Lena C, Picciotto MR, Changeux J-P. Identification of four classes of brain nicotinic receptors using β2 mutant mice. J Neurosci 1998; 18: 4461-72
4. Jones S, Sudweeks S, Yakel JL. Nicotinic receptors in the brain: correlating physiology with function. Trends Neurosci 1999; 22: 555-61
5. Li D-P, Pan Y-Z, Pan H-L. Acetylcholine attenuates synaptic GABA release to supraoptic neurons through presynaptic nicotinic receptors. Brain Res 2001; 920: 151-8
6. Schilstrom B, Fagerquist MV, Zhang X, Hertel P, Panagis G, Nomikos GG, Svensson TH. Putative role of presynaptic α7 nicotinic receptors in nicotine stimulated increases of extracellular levels of glutamate and aspartate in the ventral tegmental area. Synapse 2000; 38: 375-83
7. Wan H, Aggleton JP, Brown MW. Different contributions of the hippocampus and perirhinal cortex to recognition memory. J Neurosci 1999; 19: 1142-8
8. Paterson D, Nordberg A. Neuronal nicotinic receptors in the human brain. Prog Neurobiol 2000; 61: 75-111
9. Auta J, Longone P, Guidotti A, Costa E. The regulation of hippocampal nicotinic acetylcholine receptors (nAChRs) after a protracted treatment with selective or nonselective nAChR agonists. J Mol Neurosci 1999; 13: 31-45
10. Molinari EJ, Delbono O, Messi ML, Renganathan M, Arneric SP, Sullivan JP, Gopalakrishnan M. Up-regulation of human α7 nicotinic receptors by chronic treatment with activator and antagonist ligands. Eur J Pharmacol 1998; 347: 131-9
11. Wenger BW, Bryant DL, Boyd RT, McKay DB. Evidence for spare nicotinic acetylcholine receptors and a β4 subunit in bovine adrenal chromaffin cells: studies using bromoacetylcholine, epibatidine, cytisine and mAb35. J Pharmacol Exp Ther 1997; 281: 905-13
12. Graves AB, van Duijn CM, Chandra V, Fratiglioni L, Heyman A, Jorm AF, Kokmen E, Kondo K, Mortimer JA, Rocca WA. Alcohol and tobacco consumption as risk factors for Alzheimer's disease: a collaborative re-analysis of case-control studies. EURODEM Risk Factors Research Group. Int J Epidemiol 1991; 20: S48-57
13. Brenner DE, Kukull WA, van Belle G, Bowen JD, McCormick WC, Teri L, Larson EB. Relationship between cigarette smoking and Alzheimer's disease in a population-based case-control study. Neurology 1993; 43: 293-300
14. Debanne SM, Rowland DY, Riedel TM, Cleves MA. Association of Alzheimer's disease and smoking: the case for sibling controls. J Am Geriatr Soc 2000; 48: 800-6
15. Grandinetti A, Morens DM, Reed D, MacEachern D. Prospective study of cigarette smoking and the risk of developing idiopathic Parkinson's disease. Am J Epidemiol 1994; 139: 1129-38
16. Hernan MA, Zhang SM, Rueda-deCastro AM, Colditz GA, Speizer FE, Ascherio A. Cigarette smoking and the incidence of Parkinson's disease in two prospective studies. Ann Neurol 2001; 50: 780-6
17. Ishikawa A, Miyatake T. Effects of smoking in patients with early-onset Parkinson's disease. J Neurol Sci 1993; 117: 28-32
18. Kihara T, Shimohama S, Urushitani M, Sawada H, Kimura J, Kume T, Maeda T, Akaike A. Stimulation of α4β2 nicotinic acetylcholine receptors inhibits β-amyloid toxicity. Brain Res 1998; 792: 331-4
19. Kihara T, Shimohama S, Sawada H, Kimura J, Kume T, Kochiyama H, Maeda T, Akaike A. Nicotinic receptor stimulation protects neurons against beta-amyloid toxicity. Ann Neurol 1997; 42: 159-63
20. Maggio R, Riva M, Vaglini F, Fornai F, Molteni R, Armogida M, Racagni G, Corsini GU. Nicotine prevents experimental parkinsonism in rodents and induces striatal increase of neurotrophic factors. J Neurochem 1998; 71: 2439-46
21. Breese CR, Lee MJ, Adams CE, Sullivan B, Logel J, Gillen KM, Marks MJ, Collins AC, Leonard S. Abnormal regulation of high affinity nicotinic receptors in subjects with schizophrenia. Neuropsychopharmacology 2000; 23: 351-64
22. Court JA, Lloyd S, Thomas N, Piggott MA, Marshall EF, Morris CM, Lamb H, Perry RH, Johnson M, Perry EK. Dopamine and nicotinic receptor binding and the levels of dopamine and homovanillic acid in human brain related to tobacco use. Neuroscience 1998; 87: 63-78
23. Marks MJ, Pauly JR, Gross SD, Deneris ES, Hermans-Borgmeyer I, Heinemann SF, Collins AC. Nicotine binding and nicotinic receptor subunit RNA after chronic nicotine treatment. J Neurosci 1992; 12: 2765-84
24. Perry DC, Davila-Garcia MI, Stockmeier CA, Kellar KJ. Increased nicotinic receptors in brains from smokers: membrane binding and autoradiography studies. J Pharmacol Exp Ther 1999; 289: 1545-52
25. 3H]-epibatidine binding sites. Neuropharmacology 1997; 36: 1119-25
26. Martin-Ruiz CM, Court JA, Molnar E, Lee M, Gotti C, Mamalaki A, Tsouloufis T, Tzartos S, Ballard C, Perry RH, Perry EK. Alpha4 but not alpha3 and alpha7 nicotinic acetylcholine receptor subunits are lost from the temporal cortex in Alzheimer's disease. J Neurochem 1999; 73: 1635-40
27. Pauly JR, Marks MJ, Gross SD, Collins AC. An autoradiographic analysis of cholinergic receptors in mouse brain after chronic nicotine treatment. J Pharmacol Exp Ther 1991; 258: 1127-36
28. Sparks JA, Pauly JR. Effects of continuous oral nicotine administration on brain nicotinic receptors and responsiveness to nicotine in C57Bl/6 mice. Psychopharmacology (Berl) 1999; 141: 145-53
29. Sanderson EM, Drasdo AL, McCrea K, Wonnacott S. Upregulation of nicotinic receptors following continuous infusion of nicotine is brain-region-specific. Brain Res 1993; 617: 349-52
30. Alvarez P, Zola-Morgan S, Squire LR. Damage limited to the hippocampal region produces long-lasting memory impairment in monkeys. J Neurosci 1995; 15: 3796-807
31. Otto T, Wolf D, Walsh TJ. Combined lesions of perirhinal and entorhinal cortex impair rats' performance in two versions of the spatially guided radial-arm maze. Neurobiol Learn Mem 1997; 68: 21-31
32. Agulhon C, Charnay Y, Vallet P, Abitbol M, Kobetz A, Bertrand D, Malafosse A. Distribution of mRNA for the α4 subunit of the nicotinic acetylcholine receptor in the human fetal brain. Mol Brain Res 1998; 58: 123-31
33. Guan ZZ, Zhang X, Ravid R, Nordberg A. Decreased protein levels of nicotinic receptor subunits in the hippocampus and temporal cortex of patients with Alzheimer's disease. J Neurochem 2000; 74: 237-43
34. Hellstrom-Lindahl E, Court JA. Nicotinic acetylcholine receptors during prenatal development and brain pathology in human aging. Behav Brain Res 2000; 113: 159-68
35. Sudweeks SN, Yakel JL. Functional and molecular characterization of neuronal nicotinic ACh receptors in rat CA1 hippocampal neurons. J Physiol 2000; 527: 515-28
36. Wevers A, Burghaus L, Moser N, Witter B, Steinlein OK, Schutz U, Achnitz B, Krempel U, Nowacki S, Pilz K, Stoodt J, Lindstrom J, De Vos RA, Jansen Steur EN, Schroder H. Expression of nicotinic acetylcholine receptors in Alzheimer's disease: postmortem investigations and experimental approaches. Behav Brain Res 2000; 113: 207-15
37. Teaktong T, Graham A, Court J, Perry R, Jaros E, Johnson M, Hall R, Perry E. Alzheimer's disease is associated with a selective increase in α7 nicotinic acetylcholine receptor immunoreactivity in astrocytes. Glia 2003; 41: 207-11
38. Graham A, Court JA, Martin-Ruiz CM, Jaros E, Perry R, Volsen SG, Bose S, Evans N, Ince P, Kuryatov A, Lindstrom J, Gotti C, Perry EK. Immunohistochemical localisation of nicotinic acetylcholine receptor subunits in human cerebellum. Neuroscience 2002; 113: 493-507
39. Schoepfer R, Conroy WG, Whiting P, Gore M, Lindstrom J. Brain α-bungarotoxin binding protein cDNAs and MAbs reveal subtypes of this branch of the ligand-gated ion channel gene superfamily. Neuron 1990; 5: 35-48
40. Whiting PJ, Lindstrom JM. Characterization of bovine and human neuronal nicotinic acetylcholine receptors using monoclonal antibodies. J Neurosci 1988; 8: 3395-404
41. Amarel DG, Insausti R. Hippocampal formation. In The Human Nervous System. Ed. G Paxinos. San Diego: Academic Press, 1990; 711-55
42. 3H]nicotine binding sites in human brain. J Neurochem 1988; 50: 1243-7
43. 3H]nicotine binding in human postmortem brain. J Pharmacol Exp Ther 1997; 282: 7-13
44. Alkondon M, Pereira EF, Eisenberg HM, Albuquerque EX. Nicotinic receptor activation in human cerebral cortical interneurons: a mechanism for inhibition and disinhibition of neuronal networks. J Neurosci 2000; 20: 66-75
45. Sorenson EM, Shiroyama T, Kitai ST. Postsynaptic nicotinic receptors on dopaminergic neurons in the substantia nigra pars compacta of the rat. Neuroscience 1998; 87: 659-73
46. Flores CM, Davila-Garcia MI, Ulrich YM, Kellar KJ. Differential regulation of neuronal nicotinic receptor binding sites following chronic nicotine administration. J Neurochem 1997; 69: 2216-19
47. Hellstrom-Lindahl E, Seiger A, Kjaeldgaard A, Nordberg A. Nicotine-induced alterations in the expression of nicotinic receptors in primary cultures from human prenatal brain. Neuroscience 2001; 105: 527-34
48. Whiteaker P, Sharples CG, Wonnacott S. Agonist-induced up-regulation of α4β2 nicotinic acetylcholine receptors in M10 cells: pharmacological and spatial definition. Mol Pharmacol 1998; 53: 950-62
49. Yang X, Buccafusco JJ. Comparison of the ability of direct-and indirect-acting nicotinic agonists to induce nicotinic receptor up-regulation in rat cerebral cortex. Drug Dev Res 1994; 31: 95-101
50. Collins AC, Marks MJ. Are nicotine receptors activated or inhibited following chronic nicotine treatment? Drug Dev Res 1996; 38: 231-42
51. 3H]dopamine release from mouse striatal synaptosomes. J Neurochem 1994; 62: 1390-8
52. Ke L, Eisenhour CM, Bencherif M, Lukas RJ. Effects of chronic nicotine treatment on expression of diverse nicotinic acetylcholine receptor subtypes. I. Dose- and time-dependent effects of nicotine treatment. J Pharmacol Exp Ther 1998; 286: 825-40
53. Marks MJ, Grady SR, Collins AC. Downregulation of nicotinic receptor function after chronic nicotine infusion. J Pharmacol Exp Ther 1993; 266: 1268-76
54. + efflux from mouse brain synaptosomes. J Neurochem 1994; 63: 2125-35
55. Wonnacott S. The paradox of nicotinic acetylcholine receptor upregulation by nicotine. Trends Pharmacol Sci 1990; 11: 216-19
56. Buisson B, Bertrand D. Chronic exposure to nicotine upregulates the human α4β2 nicotinic acetylcholine receptor function. J Neurosci 2001; 21: 1819-29
57. Fenster CP, Rains MF, Noerager B, Quick MW, Lester RA. Influence of subunit composition on desensitization of neuronal acetylcholine receptors at low concentrations of nicotine. J Neurosci 1997; 17: 5747-59
58. Olale F, Gerzanich V, Kuryatov A, Wang F, Lindstrom J. Chronic nicotine exposure differentially affects the function of human α3, α4, and α7 neuronal nicotinic receptor subtypes. J Pharmacol Exp Ther 1997; 283: 675-83
59. Yu ZJ, Wecker L. Chronic nicotine administration differentially affects neurotransmitter release from rat striatal slices. J Neurochem 1994; 63: 186-94
60. Dani JA, Heinemann S. Molecular and cellular aspects of nicotine abuse. Neuron 1996; 16: 905-8
61. Mathieu-Kia AM, Kellogg SH, Butelman ER, Kreek MJ. Nicotine addiction: insights from recent animal studies. Psychopharmacology (Berl) 2002; 162: 102-18
62. Jonnala RR, Buccafusco JJ. Relationship between the increased cell surface α7 nicotinic receptor expression and neuroprotection induced by several nicotinic receptor agonists. J Neurosci Res 2001; 66: 565-72
63. Ridley DL, Pakkanen J, Wonnacott S. Effects of chronic drug treatments on increases in intracellular calcium mediated by nicotinic acetylcholine receptors in SH-SY5Y cells. Br J Pharmacol 2002; 135: 1051-9
64. Peinado MA, Quesada A, Pedrosa JA, Torres MI, Martinez M, Esteban FJ, Del Moral ML, Hernandez R, Rodrigo J, Peinado JM. Quantitative and ultrastructural changes in glia and pericytes in the parietal cortex of the aging rat. Microsc Res Tech 1998; 43: 34-42
65. Amenta F, Bronzetti E, Sabbatini M, Vega J. Astrocyte changes in aging cerebral cortex and hippocampus: a quantitative immunohistochemical study. Microsc Res Tech 1998; 43: 29-33
66. Casolini P, Catalani A, Zuena AR, Angelucci L. Inhibition of COX-2 reduces the age-dependent increase of hippocampal inflammatory markers, corticosterone secretion, and behavioral impairments in the rat. J Neurosci Res 2002; 68: 337-43
67. Murray CA, Lynch MA. Evidence that increased hippocampal expression of the cytokine interleukin-1β is a common trigger for age- and stress-induced impairments in long-term potentiation. J Neurosci 1998; 18: 2974-81
68. Madretsma GS, Donze GJ, van Dijk AP, Tak CJ, Wilson JH, Zijlstra FJ. Nicotine inhibits the in vitro production of interleukin 2 and tumour necrosis factor-α by human mononuclear cells. Immunopharmacology 1996; 35: 47-51
69. Ouyang Y, Virasch N, Hao P, Aubrey MT, Mukerjee N, Bierer BE, Freed BM. Suppression of human IL-1β, IL-2, IFN-γ, and TNF-α production by cigarette smoke extracts. J Allergy Clin Immunol 2000; 106: 280-7